sábado, 24 de julio de 2021

Dapagliflozin in patients with COVID-19: truth or dare - The Lancet Diabetes & Endocrinology

Dapagliflozin in patients with COVID-19: truth or dare - The Lancet Diabetes & Endocrinology

No hay comentarios:

Publicar un comentario